Advertisement Aveva Drug Delivery Systems - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More

Aveva Drug Delivery Systems

Innovative Drug Delivery Solutions

January 25, 2011

Aveva Drug Delivery Systems Inc Welcomes New Director of Alliance Management and New Marketing Manager

Aveva Drug Delivery Systems Inc. hired Paul Davis as director, Alliance Management and Jared Hahn as marketing manager, both will...
pharmacuetical business review
October 28, 2009

Teva Announces FDA Approval and Commercial Launch of Fentanyl Transdermal System

20th Oct 2008 - (NASDAQ: TEVA) announced today that the US Food and Drug Administration (FDA) has granted approval for...
pharmacuetical business review


Aveva Drug Delivery Systems

AVEVA Drug Delivery Systems is a global leader in transdermal drug delivery located in the US. The company has an extensive history of providing pharmaceutical partners with fully integrated, controlled-release transdermal products that fulfill unmet market needs or supply high-quality, affordable brand equivalents.

Capable of producing transdermal pharmaceutical products

By leveraging this experience, AVEVA offers a full range of research, development and manufacturing capabilities to produce transdermal pharmaceutical products that can improve the quality of life, usage and compliance rates for patients.

AVEVA uses a number of sophisticated technologies to produce proprietary and generic transdermal drug delivery systems that fortify R&D pipelines and enhance compounds by:

  • Enhancing bioavailability via bypassing first pass metabolism
  • Minimizing pharmaco-kinetic peaks and troughs
  • Improving tolerability and dosing
  • Increasing patient compliance
  • Continous delivery

Commercial successes can be found in the following therapeutic categories:

  • Smoking cessation
  • Pain management
  • Cardiovascular disease
  • Dermatologicals
  • Nutraceuticals
  • Central nervous system

Approved AVEVA products:

  • Fentanyl Transdermal Patch (pain): approved in the US and Canada in 2008
  • Clonidine Transdermal Patch (hypertension): approved in the US August 2009
  • Clearback Nicotine Transdermal Patch (smoking cessation): approved in the US, Canada, Korea and Colombia

Customized transdermal drug delivery systems

AVEVA’s deal configurations are designed for maximum flexibility in accordance with the needs of partners, and are as unique to each client as AVEVA’s customized transdermal drug delivery systems:

  • Challenge our scientists to perform feasibility studies for transdermal administration of your product using innovative techniques in computer modelling and cadaver skin permeation testing
  • Collaborate with us on R&D for new chemical entities (NCE) and accretive lifecycle management (LCM) of portfolio compounds
  • Capitalize on global opportunities for commercialization of approved products from Aveva Drug Delivery Systems

Overcoming formulation challenges with creative solutions

At AVEVA Drug Delivery Systems, we don’t employ just one process in the development of transdermal drug delivery systems.

AVEVA creates individualized systems that are specifically designed for the chemical entity, rapidly and cost-effectively generating unique products to meet specialized needs.

AVEVA clearly recognizes and understands the need for leading-edge capabilities and innovative technologies in order to open up a growing pool of new pharmaceutical compounds for transdermal drug delivery.


Aveva Drug Delivery Systems
3250 Commerce Parkway
Miramar, Florida 33025
Tel: + 1-954-430-3340
Fax: + 1-954-430-3390

Contact Person:
Robert J. Bloder
Vice President, Business Development
+ 1-954-624-1374

Quick Contact Aveva Drug Delivery Systems

Top Products from Aveva Drug Delivery Systems


(Launched in the US - rest of the world available) - The Clonidine patch is the generic version of the Catapres-TTS® (clonidine) transdermal therapeutic system, which is the only seven-day patch indicated in the treatment of hypertension.


(Launched in the US & Canada - rest of the world available) - The generic version of the Duragesic patch, the Fentanyl patch, is a narcotic (opioid) pain medicine applied to the skin for treating persistent moderate to severe pain in opioid-tolerant patients who need to be on a narcotic pain medicine around-the-clock for more…


(Isosorbide Dinitrate) - The Isosorbide Dinitrate patch is indicated for the prevention of angina pectoris due to coronary artery disease.Please contact us for more information.


The Lidoderm generic patch is indicated for pre-venous cannulation.Please contact us for more information.

Nicotine Clear

(Approved in the US, Canada and Latin America) - This Nicotine Transdermal System delivers 21mg, 14mg and 7mg respectively of nicotine over a 24 hour period. Indicated for smoking cessation, it reduces withdrawal symptoms, including nicotine cravings associated with quitting smoking. Please contact us for more information.


(Global rights available) - The generic Sufentanil patch is an opioid analgesic. Sufentanil has been reported to be as much as ten times as potent as Fentanyl. For more information please contact us.


The Tolebuterol patch or Hokunalin® Tape is the world's first transdermal long-acting b2 agonist preparation, which was co-developed by Abbott Japan Co., Ltd. and Nitto Denko Corporation, and has been available since December 1998. Hokunalin® Tape contains tulobuterol as the active ingredient, and is effective for 24 hours. It is indicated for "treatment of signs/symptoms…
Quick Contact Aveva Drug Delivery Systems
Quick Contact Aveva Drug Delivery Systems

Quick Contact Aveva Drug Delivery Systems
Quick Contact Aveva Drug Delivery Systems
Quick Contact Aveva Drug Delivery Systems

Contact Aveva Drug Delivery Systems

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.


Finally, complete a quick security check and confirm terms and conditions:

Quick Contact Aveva Drug Delivery Systems